Unknown NA INTERVENTIONAL 2-arm NCT01686542

CPVI Plus Renal Sympathetic Modification Versus CPVI Alone for AF（Atrial Fibrillation） Ablation

Circumferential Pulmonary Vein Isolation (CPVI) Plus Renal Sympathetic Modification Versus CPVI Alone for AF Ablation: a Pilot Study

Sponsor: The Second Affiliated Hospital of Chongqing Medical University

Conditions Atrial Fibrillation

Interventions CPVI CPVI plus renal sympathetic modification

Updated 8 times since 2017 Last updated: Mar 18, 2019 Started: Jun 30, 2012 Primary completion: Dec 31, 2019 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01686542, this NA trial focuses on Atrial Fibrillation and remains ongoing. Sponsored by The Second Affiliated Hospital of Chongqing Medical University, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Apr 2019 — Jan 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jun 2018 — Apr 2019 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Second Affiliated Hospital of Chongqing Medical University

Data source: The Second Affiliated Hospital of Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China